Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latvian Health Minister

This article was originally published in SRA

Executive Summary

Parliament approves new ministerial cabinet

Parliament approves new ministerial cabinet

The Latvian Saeima (parliament) has approved the new cabinet of ministers, headed by Prime Minister Aigars Kalvitis1. Gundars Berzins, previously minister for finance, was appointed as health minister2. Both Mr Kalvitis and Mr Berzins are representatives of the Peoples’ Party.

Following his appointment, Mr Berzins proposed changes to the national healthcare system including plans to extend full or partial reimbursement for medicines that treat cancer and haematological and kidney disorders as well as medicines containing growth hormones.

The approval of the new coalition cabinet - voted for on 2 December 2004 by a sweeping majority of MPs - ends the authority of the previous, short-lived, government headed by Indulis Emsis, which collapsed after parliament voted against the 2005 budget3. It caps a year in which Latvia joined the European Union (EU) and the North Atlantic Treaty Organization (NATO).

References

1. The Cabinet of Ministers of the Republic of Latvia press release, 2 December 2004, www.mk.gov.lv

2. The Cabinet of Ministers of the Republic of Latvia, Composition of the cabinet of ministers, 2 December 2004, www.mk.gov.lv

3. US Department of State, Background Note: Latvia, December 2004, www.state.gov/r/pa/ei/bgn/5378.htm

Latest Headlines
See All
UsernamePublicRestriction

Register

PS110333

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel